Nearwater Capital Markets, Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1915842 NEW YORK, NY

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,863,200

-$19,292,900 QoQ

Shares Held

5,000

-83.3% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nearwater Capital Markets, Ltd holds $476,932,369 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,097,000	$392,726,160
2	ROIV	Roivant Sciences Ltd.	1,500,000	$53,085,000
3	NKTR	Nektar Therapeutics	261,500	$18,255,315
4	ARQT	Arcutis Biotherapeutics, Inc.	486,700	$12,761,274
5	CELC	Celcuity Inc.	1,000	$104,620

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,863,200	5,000	-83.3%	Shares	Sole	2026-05-15
2025-12-31	$23,156,100	30,000	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.